Postoperative adjuvant therapy after transoral robotic resection for oropharyngeal carcinomas: Rationale and current treatment approach

ORL

Volumn 73, Issue 3, 2011, Pages 121-130

  Quon, Harry ^a,b,c   O'Malley Jr , Bert W ^a,b   Weinstein, Gregory S ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Concurrent chemotherapy; Oropharynx; Postoperative adjuvant therapy; Radiation; Transoral robotic surgery

Indexed keywords

CISPLATIN;

CANCER ADJUVANT THERAPY; CANCER CHEMORADIOTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; HUMAN; OROPHARYNX CARCINOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ROBOTICS; SURGICAL TECHNIQUE;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; ORAL SURGICAL PROCEDURES; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY; ROBOTICS;

EID: 79952337568     PISSN: 03011569     EISSN: 14230275     Source Type: Journal    
DOI: 10.1159/000319890     Document Type: Review

References (43)

1. O'Malley BW Jr, Weinstein GS, Snyder W, Hockstein NG: Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 2006; 116:1465-1472. (Pubitemid 44181466)
2. Grant DG, Salassa JR, Hinni ML, Pearson BW, Perry WC: Carcinoma of the tongue base treated by transoral laser microsurgery 2. Persistent, recurrent and second primary tumors. Laryngoscope 2006; 116:2156-2161. (Pubitemid 44912311)
3. Grant DG, Salassa JR, Hinni ML, Pearson BW, Perry WC: Carcinoma of the tongue base treated by transoral laser microsurgery 1. Untreated tumors, a prospective analysis of oncologic and functional outcomes. Laryngoscope 2006; 116:2150-2155. (Pubitemid 44912310)
4. Weinstein GS, O'Malley BW Jr, Snyder W, Sherman E, Quon H: Transoral robotic sur-gery: radical tonsillectomy. Arch Otolaryn-gol Head Neck Surg 2007; 133: 1220-1226. (Pubitemid 350294250)
5. Steiner W, Fierek O, Ambrosch P, Homme-rich CP, Kron M: Transoral laser microsur-gery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 2003; 129:36-43. (Pubitemid 36070874)
6. Grant DG, Hinni ML, Salassa JR, Perry WC, Hayden RE, Casler JD: Oropharyngeal can-cer: a case for single modality treatment with transoral laser microsurgery. Arch Otolar-yngol Head Neck Surg 2009; 135:1225-1230.
7. Fletcher GH, Evers WT: Radiotherapeutic management of surgical recurrences and postoperative residuals in tumors of the head and neck. Radiology 1970; 95: 185-188.
8. Hamberger AD, Fletcher GH, Guillamonde-gui OM, Byers RM: Advanced squamous cell carcinoma of the oral cavity and oropharynx treated with irradiation and surgery. Radiology 1976; 119:433-438.
9. Tupchong L, Scott CB, Blitzer PH, Marcial VA, Lowry LD, Jacobs JR, et al: Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 1991; 20:21-28.
10. Feldman M, Fletcher GH: Analysis of the pa-rameters relating to failures above the clavi-cles in patients treated by postoperative ir-radiation for squamous cell carcinomas of the oral cavity or oropharynx. Int J Radiat Oncol Biol Phys 1982; 8:27-30. (Pubitemid 12136701)
11. Peters LJ, Goepfert H, Ang KK, Byers RM, Maor MH, Guillamondegui O, et al: Evalua-tion of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Ra-diat Oncol Biol Phys 1993; 26: 3-11. (Pubitemid 23137882)
12. Ang KK, Peters LJ, Weber RS, Morrison WH, Frankenthaler RA, Garden AS, et al: Postop-erative radiotherapy for cutaneous melano-ma of the head and neck region. Int J Radiat Oncol Biol Phys 1994; 30:795-798. (Pubitemid 24355927)
13. Pfreundner L, Willner J, Marx A, Hoppe F, Beckmann G, Flentje M: The influence of the radicality of resection and dose of postop-erative radiation therapy on local control and survival in carcinomas of the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 2000; 47:1287-1297. (Pubitemid 30421182)
14. Marcus RB Jr, Million RR, Cassissi NJ: Post-operative irradiation for squamous cell car-cinomas of the head and neck: analysis of time-dose factors related to control above the clavicles. Int J Radiat Oncol Biol Phys 1979; 5: 1943-1949. (Pubitemid 10177988)
15. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al: Randomized trial addressing risk features and time fac-tors of surgery plus radiotherapy in ad-vanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 571-578.
16. Suwinski R, Sowa A, Rutkowski T, Wyd-manski J, Tarnawski R, Maciejewski B: Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients. Int J Radiat Oncol Biol Phys 2003; 56: 399-412. (Pubitemid 36542899)
17. Hosal AS, Unal OF, Ayhan A: Possible prog-nostic value of histopathologic parameters in patients with carcinoma of the oral tongue. Eur Arch Otorhinolaryngol 1998; 255:216-219. (Pubitemid 28192691)
18. Unal OF, Ayhan A, Hosal AS: Prognostic val-ue of p53 expression and histopathological parameters in squamous cell carcinoma of oral tongue. J Laryngol Otol 1999; 113:446-450. (Pubitemid 29238018)
19. O'Donnell RK, Feldman M, Mick R, Muschel RJ: Immunohistochemical method identifies lymphovascular invasion in a majority of oral squamous cell carcinomas and discrim-inates between blood and lymphatic vessel invasion. J Histochem Cytochem 2008; 56: 803-810.
20. Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA, Silverman JF: Lymphatic mi-crovessel density as prognostic marker in colorectal cancer. Mod Pathol 2006; 19: 1317-1323. (Pubitemid 44423078)
21. Sakuragi N, Takeda N, Hareyama H, Fuji-moto T, Todo Y, Okamoto K, et al: A multi-variate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cer-vical carcinoma. Cancer 2000; 88: 2578-2583. (Pubitemid 30331966)
22. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al: Postopera-tive concurrent radiotherapy and chemo-therapy for high-risk squamous-cell carci-noma of the head and neck. N Engl J Med 2004; 350: 1937-1944.
23. Bernier J, Domenge C, Ozsahin M, Matus-zewska K, Lefebvre JL, Greiner RH, et al: Postoperative irradiation with or without concomitant chemotherapy for locally ad-vanced head and neck cancer. N Engl J Med 2004; 350: 1945-1952. (Pubitemid 38580197)
24. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al: Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concur-rent postoperative radiation plus chemo-therapy trials of the EORTC (No 22931) and RTOG (No 9501). Head Neck 2005; 27:843-850. (Pubitemid 41395696)
25. Pignon J-P, le Maître A, Bourhis J: Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 2007; 69(suppl 1):S112-S114. (Pubitemid 47369400)
26. Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, et al: Factors as-sociated with severe late toxicity after con-current chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589.
27. Langendijk JA, Doornaert P, Rietveld DH, Verdonck-de Leeuw IM, Leemans CR, Slot-man BJ: A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol 2009; 90: 189-195.
28. Eckel HE, Volling P, Pototschnig C, Zorowka P, Thumfart W: Transoral laser resection with staged discontinuous neck dissection for oral cavity and oropharynx squamous cell carcinoma. Laryngoscope 1995; 105: 53-60.
29. Rusthoven KE, Raben D, Schneider C, Witt R, Sammons S, Raben A: Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach. Int J Radiat Oncol Biol Phys 2009; 74:1365-1370.
30. O'Sullivan B, Warde P, Grice B, Goh C, Payne D, Liu FF, et al: The benefits and pit-falls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 2001; 51: 332-343. (Pubitemid 32884279)
31. Weinstein GS, Quon H, O'Malley BW Jr, Kim GG, Cohen MA: Selective neck dissec-tion and de-intensified postoperative radia-tion and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania TORS trial. Laryngoscope, in press.
32. Ambrosch P, Freudenberg L, Kron M, Stei-ner W: Selective neck dissection in the management of squamous cell carcinoma of the upper digestive tract. Eur Arch Oto-rhinolaryngol 1996; 253:329-335. (Pubitemid 26258588)
33. Goldenberg D, Begum S, Westra WH, Khan Z, Sciubba J, Pai SI, et al: Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008; 30:898-903. (Pubitemid 352008950)
34. Kenji K, Hiroki S, Takeshi N, Takuro A, Sei-ko H, Masanori K, et al: Ipsilateral irradia-tion for carcinomas of tonsillar region and soft palate based on computed tomographic simulation. Radiother Oncol J Eur Soc Ther Radiol Oncol 2000; 54:117-121.
35. Levendag P, Nijdam W, Noever I, Schmitz P, van de Pol M, Sipkema D, et al: Brachyther-apy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more se-lective and obtain better tissue sparing? Int J Radiat Oncol Biol Phys 2004; 59: 713-724. (Pubitemid 38748737)
36. Jackson SM, Hay JH, Flores AD, Weir L, Wong FL, Schwindt C, et al: Cancer of the tonsil: the results of ipsilateral radiation treatment. Radiother Oncol 1999; 51: 123-128. (Pubitemid 29320304)
37. Murthy AK, Hendrickson FR: Is contralateral neck treatment necessary in early carcinoma of the tonsil? Int J Radiat Oncol Biol Phys 1980; 6:91-94. (Pubitemid 10155038)
38. Lim YC, Lee SY, Lim JY, Shin HA, Lee JS, Koo BS, et al: Management of contralateral N0 neck in tonsillar squamous cell carcino-ma. Laryngoscope 2005; 115:1672-1675. (Pubitemid 41330682)
39. Bussels B, Hermans R, Reijnders A, Dirix P, Nuyts S, van den Bogaert W: Retropharyn-geal nodes in squamous cell carcinoma of oropharynx: incidence, localization, and im-plications for target volume. Int J Radiat On-col Biol Phys 2006; 65:733-738. (Pubitemid 43795855)
40. Hasegawa Y, Matsuura H: Retropharyngeal node dissection in cancer of the oropharynx and hypopharynx. Head Neck 1994; 16:173-180. (Pubitemid 24080613)
41. McLaughlin MP, Mendenhall WM, Mancu-so AA, Parsons JT, McCarty PJ, Cassisi N J, et al: Retropharyngeal adenopathy as a predic-tor of outcome in squamous cell carcinoma of the head and neck. Head Neck 1995; 17: 190-198.
42. Meier JD, Oliver DA, Varvares MA: Surgical margin determination in head and neck on-cology: current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck 2005; 27: 952-958. (Pubitemid 41552138)
43. Dosoretz A, Dutta PR, Lin A, Alonso-Basan-ta M, Barad V, Both S, et al: Long-term per-cutaneous gastrostomy tube dependence rates in patients treated with intensity-mod-ulated radiotherapy for oropharyngeal can-cer: the University of Pennsylvania experi-ence (poster 14). Int J Radiat Oncol Biol Phys, submitted.